The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors.
 
Thomas Cash
Consulting or Advisory Role - EUSA Pharma
Research Funding - Celgene
Travel, Accommodations, Expenses - EUSA Pharma
 
Hunter C. Jonus
No Relationships to Disclose
 
Maya Tsvetkova
No Relationships to Disclose
 
Jan Hendrik Beumer
Employment - Cardinal Health (I); Voisin Consulting (I)
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Research Funding - Abbvie (Inst); Spectrum Pharmaceuticals (Inst); Taiho Pharmaceutical (Inst)
Patents, Royalties, Other Intellectual Property - Sulphoraphane for melanoma chemoprevention (Inst)
 
Jasmine Y Lee
No Relationships to Disclose
 
Curtis Henry
No Relationships to Disclose
 
Dolly Aguilera
No Relationships to Disclose
 
R. Donald Harvey
No Relationships to Disclose
 
Kelly C. Goldsmith
No Relationships to Disclose